世界の血漿タンパク質治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Plasma Protein Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4642 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、血漿タンパク質治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（凝固因子、免疫グロブリン、アルブミン、その他）、用途別市場規模（血友病、PID、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・血漿タンパク質治療薬の市場動向 ・企業の競争状況、市場シェア ・血漿タンパク質治療薬の種類別市場規模（凝固因子、免疫グロブリン、アルブミン、その他） ・血漿タンパク質治療薬の用途別市場規模（血友病、PID、その他） ・血漿タンパク質治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・血漿タンパク質治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・血漿タンパク質治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血漿タンパク質治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・血漿タンパク質治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Shire (Baxalta)、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Kamada） ・結論

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature’s raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Plasma Protein Therapeutics is widely used to treat Hemophilia, PID and Other. The most proportion of Plasma Protein Therapeutics is to treat PID, and the proportion is about 36.1% in 2017. North America is the largest sales place, with a consumption value market share nearly 37% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 23.7% in 2017. China is an important market of Blood Product in Asia, accounting for 13.4% revenue market share of global market. Baxter, CSL, Grifols are the leaders of the industry, with 71.6% market share in 2017, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.

Market Analysis and Insights: Global Plasma Protein Therapeutics Market
The global Plasma Protein Therapeutics market size is projected to reach US$ 39000 million by 2026, from US$ 24490 million in 2019, at a CAGR of 6.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasma Protein Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasma Protein Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasma Protein Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasma Protein Therapeutics market.

Global Plasma Protein Therapeutics Scope and Market Size
Plasma Protein Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Protein Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Coagulation Factor
Immune Globulin
Albumin
Others

Segment by Application
Hemophilia
PID
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
Octapharma

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma Protein Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hemophilia
1.3.3 PID
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Plasma Protein Therapeutics Market Perspective (2016-2027)
2.2 Plasma Protein Therapeutics Growth Trends by Regions
2.2.1 Plasma Protein Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Plasma Protein Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Plasma Protein Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Plasma Protein Therapeutics Industry Dynamic
2.3.1 Plasma Protein Therapeutics Market Trends
2.3.2 Plasma Protein Therapeutics Market Drivers
2.3.3 Plasma Protein Therapeutics Market Challenges
2.3.4 Plasma Protein Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Plasma Protein Therapeutics Players by Revenue
3.1.1 Global Top Plasma Protein Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Plasma Protein Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Plasma Protein Therapeutics Revenue
3.4 Global Plasma Protein Therapeutics Market Concentration Ratio
3.4.1 Global Plasma Protein Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Protein Therapeutics Revenue in 2020
3.5 Plasma Protein Therapeutics Key Players Head office and Area Served
3.6 Key Players Plasma Protein Therapeutics Product Solution and Service
3.7 Date of Enter into Plasma Protein Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Plasma Protein Therapeutics Breakdown Data by Type
4.1 Global Plasma Protein Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Plasma Protein Therapeutics Forecasted Market Size by Type (2022-2027)

5 Plasma Protein Therapeutics Breakdown Data by Application
5.1 Global Plasma Protein Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Plasma Protein Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Plasma Protein Therapeutics Market Size (2016-2027)
6.2 North America Plasma Protein Therapeutics Market Size by Type
6.2.1 North America Plasma Protein Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Plasma Protein Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Plasma Protein Therapeutics Market Size by Type (2016-2027)
6.3 North America Plasma Protein Therapeutics Market Size by Application
6.3.1 North America Plasma Protein Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Plasma Protein Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Plasma Protein Therapeutics Market Size by Application (2016-2027)
6.4 North America Plasma Protein Therapeutics Market Size by Country
6.4.1 North America Plasma Protein Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Plasma Protein Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Plasma Protein Therapeutics Market Size (2016-2027)
7.2 Europe Plasma Protein Therapeutics Market Size by Type
7.2.1 Europe Plasma Protein Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Plasma Protein Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Plasma Protein Therapeutics Market Size by Type (2016-2027)
7.3 Europe Plasma Protein Therapeutics Market Size by Application
7.3.1 Europe Plasma Protein Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Plasma Protein Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Plasma Protein Therapeutics Market Size by Application (2016-2027)
7.4 Europe Plasma Protein Therapeutics Market Size by Country
7.4.1 Europe Plasma Protein Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Plasma Protein Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Plasma Protein Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Plasma Protein Therapeutics Market Size by Type
8.2.1 Asia-Pacific Plasma Protein Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Plasma Protein Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Plasma Protein Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Plasma Protein Therapeutics Market Size by Application
8.3.1 Asia-Pacific Plasma Protein Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Plasma Protein Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Plasma Protein Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Plasma Protein Therapeutics Market Size by Region
8.4.1 Asia-Pacific Plasma Protein Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Plasma Protein Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Plasma Protein Therapeutics Market Size (2016-2027)
9.2 Latin America Plasma Protein Therapeutics Market Size by Type
9.2.1 Latin America Plasma Protein Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Plasma Protein Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Plasma Protein Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Plasma Protein Therapeutics Market Size by Application
9.3.1 Latin America Plasma Protein Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Plasma Protein Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Plasma Protein Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Plasma Protein Therapeutics Market Size by Country
9.4.1 Latin America Plasma Protein Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Plasma Protein Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Plasma Protein Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Plasma Protein Therapeutics Market Size by Type
10.2.1 Middle East & Africa Plasma Protein Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Plasma Protein Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Plasma Protein Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Plasma Protein Therapeutics Market Size by Application
10.3.1 Middle East & Africa Plasma Protein Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Plasma Protein Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Plasma Protein Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Plasma Protein Therapeutics Market Size by Country
10.4.1 Middle East & Africa Plasma Protein Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Plasma Protein Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Shire (Baxalta)
11.1.1 Shire (Baxalta) Company Details
11.1.2 Shire (Baxalta) Business Overview
11.1.3 Shire (Baxalta) Plasma Protein Therapeutics Introduction
11.1.4 Shire (Baxalta) Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.1.5 Shire (Baxalta) Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Plasma Protein Therapeutics Introduction
11.2.4 CSL Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Plasma Protein Therapeutics Introduction
11.3.4 Grifols Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Plasma Protein Therapeutics Introduction
11.4.4 Octapharma Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Details
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Plasma Protein Therapeutics Introduction
11.5.4 Kedrion Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Details
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Plasma Protein Therapeutics Introduction
11.6.4 LFB Group Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Plasma Protein Therapeutics Introduction
11.7.4 Biotest Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Details
11.8.2 BPL Business Overview
11.8.3 BPL Plasma Protein Therapeutics Introduction
11.8.4 BPL Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 RAAS Business Overview
11.9.3 RAAS Plasma Protein Therapeutics Introduction
11.9.4 RAAS Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 CBPO Business Overview
11.10.3 CBPO Plasma Protein Therapeutics Introduction
11.10.4 CBPO Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Details
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Plasma Protein Therapeutics Introduction
11.11.4 Hualan Bio Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.11.5 Hualan Bio Recent Development
11.12 Kamada
11.12.1 Kamada Company Details
11.12.2 Kamada Business Overview
11.12.3 Kamada Plasma Protein Therapeutics Introduction
11.12.4 Kamada Revenue in Plasma Protein Therapeutics Business (2016-2021)
11.12.5 Kamada Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Plasma Protein Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Coagulation Factor
Table 3. Key Players of Immune Globulin
Table 4. Key Players of Albumin
Table 5. Key Players of Others
Table 6. Global Plasma Protein Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Plasma Protein Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Plasma Protein Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Plasma Protein Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Plasma Protein Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Plasma Protein Therapeutics Market Share by Regions (2022-2027)
Table 12. Plasma Protein Therapeutics Market Trends
Table 13. Plasma Protein Therapeutics Market Drivers
Table 14. Plasma Protein Therapeutics Market Challenges
Table 15. Plasma Protein Therapeutics Market Restraints
Table 16. Global Plasma Protein Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Plasma Protein Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Plasma Protein Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Protein Therapeutics as of 2020)
Table 19. Ranking of Global Top Plasma Protein Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Plasma Protein Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Plasma Protein Therapeutics Product Solution and Service
Table 23. Date of Enter into Plasma Protein Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasma Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Plasma Protein Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Plasma Protein Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Plasma Protein Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Plasma Protein Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Plasma Protein Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Plasma Protein Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Plasma Protein Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Plasma Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Plasma Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Plasma Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Plasma Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Plasma Protein Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Plasma Protein Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Plasma Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Plasma Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Plasma Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Plasma Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Plasma Protein Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Plasma Protein Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Plasma Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Plasma Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Plasma Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Plasma Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Plasma Protein Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Plasma Protein Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Plasma Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Plasma Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Plasma Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Plasma Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Plasma Protein Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Plasma Protein Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Plasma Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Plasma Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Plasma Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Plasma Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Plasma Protein Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Plasma Protein Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Shire (Baxalta) Company Details
Table 64. Shire (Baxalta) Business Overview
Table 65. Shire (Baxalta) Plasma Protein Therapeutics Product
Table 66. Shire (Baxalta) Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Shire (Baxalta) Recent Development
Table 68. CSL Company Details
Table 69. CSL Business Overview
Table 70. CSL Plasma Protein Therapeutics Product
Table 71. CSL Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 72. CSL Recent Development
Table 73. Grifols Company Details
Table 74. Grifols Business Overview
Table 75. Grifols Plasma Protein Therapeutics Product
Table 76. Grifols Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Grifols Recent Development
Table 78. Octapharma Company Details
Table 79. Octapharma Business Overview
Table 80. Octapharma Plasma Protein Therapeutics Product
Table 81. Octapharma Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Octapharma Recent Development
Table 83. Kedrion Company Details
Table 84. Kedrion Business Overview
Table 85. Kedrion Plasma Protein Therapeutics Product
Table 86. Kedrion Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Kedrion Recent Development
Table 88. LFB Group Company Details
Table 89. LFB Group Business Overview
Table 90. LFB Group Plasma Protein Therapeutics Product
Table 91. LFB Group Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 92. LFB Group Recent Development
Table 93. Biotest Company Details
Table 94. Biotest Business Overview
Table 95. Biotest Plasma Protein Therapeutics Product
Table 96. Biotest Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Biotest Recent Development
Table 98. BPL Company Details
Table 99. BPL Business Overview
Table 100. BPL Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 101. BPL Recent Development
Table 102. RAAS Company Details
Table 103. RAAS Business Overview
Table 104. RAAS Plasma Protein Therapeutics Product
Table 105. RAAS Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 106. RAAS Recent Development
Table 107. CBPO Company Details
Table 108. CBPO Business Overview
Table 109. CBPO Plasma Protein Therapeutics Product
Table 110. CBPO Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 111. CBPO Recent Development
Table 112. Hualan Bio Company Details
Table 113. Hualan Bio Business Overview
Table 114. Hualan Bio Plasma Protein Therapeutics Product
Table 115. Hualan Bio Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 116. Hualan Bio Recent Development
Table 117. Kamada Company Details
Table 118. Kamada Business Overview
Table 119. Kamada Plasma Protein Therapeutics Product
Table 120. Kamada Revenue in Plasma Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 121. Kamada Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Protein Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Coagulation Factor Features
Figure 3. Immune Globulin Features
Figure 4. Albumin Features
Figure 5. Others Features
Figure 6. Global Plasma Protein Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hemophilia Case Studies
Figure 8. PID Case Studies
Figure 9. Others Case Studies
Figure 10. Plasma Protein Therapeutics Report Years Considered
Figure 11. Global Plasma Protein Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Plasma Protein Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Plasma Protein Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Plasma Protein Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Plasma Protein Therapeutics Market Share by Players in 2020
Figure 16. Global Top Plasma Protein Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Protein Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Plasma Protein Therapeutics Revenue in 2020
Figure 18. Global Plasma Protein Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Plasma Protein Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Plasma Protein Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Plasma Protein Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Plasma Protein Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Plasma Protein Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Plasma Protein Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Plasma Protein Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Plasma Protein Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Plasma Protein Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Plasma Protein Therapeutics Market Share by Region (2016-2027)
Figure 40. China Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Plasma Protein Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Plasma Protein Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Plasma Protein Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Plasma Protein Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Plasma Protein Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Plasma Protein Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Plasma Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Shire (Baxalta) Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 60. CSL Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 61. Grifols Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 62. Octapharma Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 63. Kedrion Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 64. LFB Group Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 65. Biotest Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 66. BPL Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 67. RAAS Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 68. CBPO Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 69. Hualan Bio Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 70. Kamada Revenue Growth Rate in Plasma Protein Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---